Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile

Cara M. Cannon, Jackson S. Musuuza, Anna K. Barker, Megan Duster, Mark B. Juckett, Aurora E. Pop-Vicas, Nasia Safdar

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions.

Original languageEnglish (US)
Pages (from-to)718-720
Number of pages3
JournalInfection Control and Hospital Epidemiology
Volume38
Issue number6
DOIs
StatePublished - Jun 1 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved.

Fingerprint

Dive into the research topics of 'Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile'. Together they form a unique fingerprint.

Cite this